[
  {
    "Drug Ingredient": "acetaminophen",
    "Reference Brand Name": "Tylenol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: acetaminophen\nBrand Example: Tylenol\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "acetyl l-carnitine",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: acetyl l-carnitine\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "acyclovir",
    "Reference Brand Name": "Zovirax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: acyclovir\nBrand Example: Zovirax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "adalimumab",
    "Reference Brand Name": "Humira",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: adalimumab\nBrand Example: Humira\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nCOVID-19 Coronavirus: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "albuterol sulfate",
    "Reference Brand Name": "Proventil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: albuterol sulfate\nBrand Example: Proventil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "alcaftadine",
    "Reference Brand Name": "Lastacaft",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: alcaftadine\nBrand Example: Lastacaft\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "alclometasone dipropionate",
    "Reference Brand Name": "Aclovate",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: alclometasone dipropionate\nBrand Example: Aclovate\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "alendronate sodium",
    "Reference Brand Name": "Fosamax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: alendronate sodium\nBrand Example: Fosamax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "almotriptan malate",
    "Reference Brand Name": "Axert",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: almotriptan malate\nBrand Example: Axert\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "alpha lipoic acid",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: alpha lipoic acid\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Alternative Mediciines\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "alprazolam",
    "Reference Brand Name": "Xanax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: alprazolam\nBrand Example: Xanax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "amantadine hcl",
    "Reference Brand Name": "Symmetrel",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: amantadine hcl\nBrand Example: Symmetrel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiparkinson Agents (NMDA receptor antagonist)\nReference in ACOEM Guidelines:\nLow Back Disorders: Not Recommended\nTraumatic Brain Injury: Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "amcinonide",
    "Reference Brand Name": "Cyclocort",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: amcinonide \nBrand Example: Cyclocort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "amitriptyline hcl",
    "Reference Brand Name": "Elavil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: amitriptyline hcl\nBrand Example: Elavil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "amlodipine besylate",
    "Reference Brand Name": "Norvasc",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: amlodipine besylate\nBrand Example: Norvasc\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Calcium Channel Blockers\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "amoxapine",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: amoxapine\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "amoxicillin/clavulanate p",
    "Reference Brand Name": "Augmentin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: amoxicillin/clavulanate p\nBrand Example: Augmentin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nLow Back Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "anakinra",
    "Reference Brand Name": "Kineret",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: anakinra \nBrand Example: Kineret\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-inflammatory\nReference in ACOEM Guidelines:\nKnee Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "apixaban",
    "Reference Brand Name": "Eliquis",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: apixaban\nBrand Example: Eliquis\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: \n14 Days \n\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "aprepitant",
    "Reference Brand Name": "Emend, Cinvanti",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: aprepitant\nBrand Example: Emend, Cinvanti\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "aripiprazole",
    "Reference Brand Name": "Abilify",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: aripiprazole\nBrand Example: Abilify\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: \n4 Days\nPeri-Op: Not Applicable \nDrug Class: Antipsychotic/ Antimanic Agents \nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "artificial tear ointments",
    "Reference Brand Name": "Refresh PM",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: artificial tear ointments \nBrand Example: Refresh PM\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Artificial Tears)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin c",
    "Reference Brand Name": "ascorbic acid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin c \nBrand Example: ascorbic acid\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "aspirin",
    "Reference Brand Name": "Bayer",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: aspirin\nBrand Example: Bayer\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "atenolol",
    "Reference Brand Name": "Tenormin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: atenolol\nBrand Example: Tenormin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Beta Blockers\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "atorvastatin calcium",
    "Reference Brand Name": "Lipitor",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: atorvastatin calcium\nBrand Example: Lipitor\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "azelastine ophth",
    "Reference Brand Name": "Optivar",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: azelastine ophth\nBrand Example: Optivar\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "azithromycin",
    "Reference Brand Name": "Zithromax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: azithromycin\nBrand Example: Zithromax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "azithromycin ophth",
    "Reference Brand Name": "Azasite",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: azithromycin ophth\nBrand Example: Azasite\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "bacitracin",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: bacitracin\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "baclofen",
    "Reference Brand Name": "Lioresal",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: baclofen\nBrand Example: Lioresal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "baricitinib",
    "Reference Brand Name": "Olumiant",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: baricitinib\nBrand Example: Olumiant\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "becaplermin",
    "Reference Brand Name": "Regranex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: becaplermin \nBrand Example: Regranex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "beclomethasone dipropionate",
    "Reference Brand Name": "Qvar",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: beclomethasone dipropionate\nBrand Example: Qvar\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "belsomra",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: belsomra\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "bepotastine ophth",
    "Reference Brand Name": "Bepreve",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: bepotastine ophth\nBrand Example: Bepreve\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "besifloxacin ophth",
    "Reference Brand Name": "Besivance",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: besifloxacin ophth\nBrand Example: Besivance\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Topical antibiotic\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "betamethasone",
    "Reference Brand Name": "Celestone",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: betamethasone\nBrand Example: Celestone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "betamethasone dipropionat",
    "Reference Brand Name": "Diprosone",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: betamethasone dipropionat \nBrand Example: Diprosone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "betamethasone valerate",
    "Reference Brand Name": "Valisone",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: betamethasone valerate \nBrand Example: Valisone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "boswellia serrata extract",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: boswellia serrata extract\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "brexpiprazole",
    "Reference Brand Name": "Rexulti",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: brexpiprazole\nBrand Example: Rexulti\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "bromfenac",
    "Reference Brand Name": "Prolensa",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: bromfenac\nBrand Example: Prolensa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "bromocriptine mesylate",
    "Reference Brand Name": "Parlodel",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: bromocriptine mesylate\nBrand Example: Parlodel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiparkinson and Related Therapy Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "budesonide",
    "Reference Brand Name": "Pulmicort",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: budesonide\nBrand Example: Pulmicort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "budesonide/formoterol",
    "Reference Brand Name": "Symbicort",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: budesonide/formoterol\nBrand Example: Symbicort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "buprenorphine",
    "Reference Brand Name": "Butrans",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: buprenorphine\nBrand Example: Butrans\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics-Opioid\nReference in ACOEM Guidelines:\nOpioids: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "buprenorphine (hcl)",
    "Reference Brand Name": "Belbuca",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: buprenorphine (hcl)\nBrand Example: Belbuca\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "buprenorphine hcl/naloxone",
    "Reference Brand Name": "Suboxone, Zubsolv",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: buprenorphine hcl/naloxone\nBrand Example: Suboxone, Zubsolv\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "bupropion hcl",
    "Reference Brand Name": "Wellbutrin, Wellbutrin XL, Wellbutrin SR",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: bupropion hcl\nBrand Example: Wellbutrin, Wellbutrin XL, Wellbutrin SR\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, No Recommendation\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "buspirone hcl",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: buspirone hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "butalbital/apap/caffeine",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: butalbital/apap/caffeine\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "butalbital/asa/caffeine",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: butalbital/asa/caffeine\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "butenafine hcl",
    "Reference Brand Name": "Lotrimin Ultra",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: butenafine hcl \nBrand Example: Lotrimin Ultra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "butorphanol tartrate",
    "Reference Brand Name": "Stadol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: butorphanol tartrate\nBrand Example: Stadol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cabergoline",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cabergoline\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents - Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "calcitonin-salmon",
    "Reference Brand Name": "Fortical, Miacalcin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: calcitonin-salmon\nBrand Example: Fortical, Miacalcin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "calcium phosphate tribasic",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: calcium phosphate tribasic\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Minerals & Electrolytes\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "camphor",
    "Reference Brand Name": "Bengay Ultra",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: camphor\nBrand Example: Bengay Ultra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "capsaicin",
    "Reference Brand Name": "Zostrix",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: capsaicin\nBrand Example: Zostrix\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals (Topical creams and ointments)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended, No Recommendation, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "carbamazepine",
    "Reference Brand Name": "Tegretol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: carbamazepine\nBrand Example: Tegretol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "carboxymethylcellulose-glycerin ophth gel",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: carboxymethylcellulose-glycerin ophth gel\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: 0phthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "carboxymethylcellulose sodium ophthalmic",
    "Reference Brand Name": "Refresh Plus",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: carboxymethylcellulose sodium ophthalmic\nBrand Example: Refresh Plus\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Artificial Tears)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "carisoprodol",
    "Reference Brand Name": "Soma",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: carisoprodol\nBrand Example: Soma\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cefadroxil",
    "Reference Brand Name": "Duracef",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cefadroxil\nBrand Example: Duracef\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Cephalosporins\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cefuroxime axetil",
    "Reference Brand Name": "Ceftin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cefuroxime axetil\nBrand Example: Ceftin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Cephalosporins)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "celecoxib",
    "Reference Brand Name": "Celebrex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: celecoxib\nBrand Example: Celebrex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nDepressive Disorders: Not Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cephalexin",
    "Reference Brand Name": "Keflex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cephalexin\nBrand Example: Keflex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Cephalosporins)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "certolizumab pegol",
    "Reference Brand Name": "Cimzia",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: certolizumab pegol\nBrand Example: Cimzia\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Gastrointestinal Agents (TNF Blocker) \nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "chlordiazepoxide hcl",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: chlordiazepoxide hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "chloroquine phosphate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: chloroquine phosphate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antimalarials\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "chlorzoxazone",
    "Reference Brand Name": "Lorzone, Parafon Forte",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: chlorzoxazone\nBrand Example: Lorzone, Parafon Forte\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "choline magnesium trisalicylate",
    "Reference Brand Name": "Trilisate",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: choline magnesium trisalicylate\nBrand Example: Trilisate\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "chondroitin sulfate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: chondroitin sulfate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines (OTC nutraceutical)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ciclesonide",
    "Reference Brand Name": "Alvesco",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ciclesonide\nBrand Example: Alvesco\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ciclopirox olamine",
    "Reference Brand Name": "Loprox",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ciclopirox olamine\nBrand Example: Loprox\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cimetidine",
    "Reference Brand Name": "Tagamet",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cimetidine\nBrand Example: Tagamet\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (H2 receptor blocker) \nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ciprofloxacin",
    "Reference Brand Name": "Cipro",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ciprofloxacin\nBrand Example: Cipro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines:\n: \nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ciprofloxacin hcl ophthalmic",
    "Reference Brand Name": "Ciloxan",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ciprofloxacin hcl ophthalmic\nBrand Example: Ciloxan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "citalopram hydrobromide",
    "Reference Brand Name": "Celexa",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: citalopram hydrobromide\nBrand Example: Celexa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "citicoline",
    "Reference Brand Name": "Ceraxon",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: citicoline\nBrand Example: Ceraxon\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "clarithromycin",
    "Reference Brand Name": "Biaxin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: clarithromycin\nBrand Example: Biaxin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "clindamycin hcl",
    "Reference Brand Name": "Cleocin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: clindamycin hcl\nBrand Example: Cleocin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "clomipramine hcl",
    "Reference Brand Name": "Anafranil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: clomipramine hcl\nBrand Example: Anafranil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "clonazepam",
    "Reference Brand Name": "Klonopin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: clonazepam\nBrand Example: Klonopin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "clonidine",
    "Reference Brand Name": "Catapres",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: clonidine\nBrand Example: Catapres\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nOpioids: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "clorazepate dipotassium",
    "Reference Brand Name": "Tranxene T",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: clorazepate dipotassium\nBrand Example: Tranxene T\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antiaxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "clotrimazole antifungal",
    "Reference Brand Name": "Lotrimin AF",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: clotrimazole antifungal\nBrand Example: Lotrimin AF\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "codeine sulfate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: codeine sulfate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "codeine/acetaminophen",
    "Reference Brand Name": "Tylenol #3, Tylenol #4",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: codeine/acetaminophen\nBrand Example: Tylenol #3, Tylenol #4\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "coenzyme q10",
    "Reference Brand Name": "CoQ10",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: coenzyme q10\nBrand Example: CoQ10\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "colchicine",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: colchicine\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Gout Agents\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cortisone",
    "Reference Brand Name": "Cortone",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cortisone\nBrand Example: Cortone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "creatine monohydrate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: creatine monohydrate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cromolyn sodium",
    "Reference Brand Name": "Intal",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cromolyn sodium\nBrand Example: Intal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cromolyn sodium (opthalmic)",
    "Reference Brand Name": "Opticrom",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cromolyn sodium (opthalmic)\nBrand Example: Opticrom\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cyclobenzaprine hcl",
    "Reference Brand Name": "Flexeril",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cyclobenzaprine hcl\nBrand Example: Flexeril\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cyclopentolate hcl",
    "Reference Brand Name": "Cyclogyl",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cyclopentolate hcl\nBrand Example: Cyclogyl\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines:\nEye: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "cyclosporine",
    "Reference Brand Name": "Sandimmune",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: cyclosporine\nBrand Example: Sandimmune\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Miscellaneous Therapeutic Classes\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dalteparin",
    "Reference Brand Name": "Fragmin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dalteparin\nBrand Example: Fragmin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dantrolene sodium",
    "Reference Brand Name": "Dantrium",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dantrolene sodium\nBrand Example: Dantrium\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dehydroepiandrosterone (dhea)",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dehydroepiandrosterone (dhea)\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "desipramine hcl",
    "Reference Brand Name": "Norpramin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: desipramine hcl\nBrand Example: Norpramin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "desloratadine",
    "Reference Brand Name": "Clarinex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: desloratadine\nBrand Example: Clarinex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "desmopressin acetate",
    "Reference Brand Name": "DDAVP",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: desmopressin acetate\nBrand Example: DDAVP\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents - Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "desonide",
    "Reference Brand Name": "Desowen",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: desonide\nBrand Example: Desowen\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "desoximetasone",
    "Reference Brand Name": "Topicort",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: desoximetasone\nBrand Example: Topicort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "desvenlafaxine",
    "Reference Brand Name": "Khedezla",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: desvenlafaxine\nBrand Example: Khedezla\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended, No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "desvenlafaxine succinate",
    "Reference Brand Name": "Pristiq",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: desvenlafaxine succinate\nBrand Example: Pristiq\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended, No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dexamethasone",
    "Reference Brand Name": "Decadron",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dexamethasone\nBrand Example: Decadron\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nCOVID-19 Coronavirus: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dexamethasone sodium phosphate ophthalmic",
    "Reference Brand Name": "Maxidex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dexamethasone sodium phosphate ophthalmic\nBrand Example: Maxidex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dexlansoprazole",
    "Reference Brand Name": "Dexilant",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dexlansoprazole\nBrand Example: Dexilant\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dextromethorphan",
    "Reference Brand Name": "Delsym",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dextromethorphan\nBrand Example: Delsym\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Cough/Cold/Allergy (NMDA Receptor Antagonist)\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dextromethorphan-quinidine sulfate",
    "Reference Brand Name": "Nuedexta",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dextromethorphan-quinidine sulfate\nBrand Example: Nuedexta\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents-Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diazepam",
    "Reference Brand Name": "Valium",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diazepam\nBrand Example: Valium\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Not Recommended\nChronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diclofenac epolamine",
    "Reference Brand Name": "Flector",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diclofenac epolamine\nBrand Example: Flector\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diclofenac potassium",
    "Reference Brand Name": "Cataflam",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diclofenac potassium\nBrand Example: Cataflam\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended, No Recommendation\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diclofenac sodium",
    "Reference Brand Name": "Voltaren",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diclofenac sodium\nBrand Example: Voltaren\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics  Anti-Inflammatory\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended, No Recommendation\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diclofenac sodium (topical)",
    "Reference Brand Name": "Voltaren 1% gel",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diclofenac sodium (topical)\nBrand Example: Voltaren 1% gel\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals \nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nShoulder: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diclofenac sodium ophthalmic",
    "Reference Brand Name": "Voltaren",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diclofenac sodium ophthalmic\nBrand Example: Voltaren \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diclofenac sodium/misoprostol",
    "Reference Brand Name": "Arthrotec",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diclofenac sodium/misoprostol\nBrand Example: Arthrotec\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID/ Ulcer drug)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dicloxacillin sodium",
    "Reference Brand Name": "Dynapen",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dicloxacillin sodium\nBrand Example: Dynapen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "diflunisal",
    "Reference Brand Name": "Dolobid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: diflunisal\nBrand Example: Dolobid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dihydroergotamine mesylat",
    "Reference Brand Name": "Migranal",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dihydroergotamine mesylat\nBrand Example: Migranal\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dimenhydrinate",
    "Reference Brand Name": "Dramamine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dimenhydrinate\nBrand Example: Dramamine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dimethyl sulfoxide",
    "Reference Brand Name": "DMSO",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dimethyl sulfoxide\nBrand Example: DMSO\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Genitourinary - Misc. (Ointments and topical agents)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "divalproex sodium",
    "Reference Brand Name": "Depakote",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: divalproex sodium\nBrand Example: Depakote\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "dolasetron mesylate",
    "Reference Brand Name": "Anzemet",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: dolasetron mesylate\nBrand Example: Anzemet\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "donepezil hcl",
    "Reference Brand Name": "Aricept",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: donepezil hcl\nBrand Example: Aricept\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents-Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "doxazosin mesylate",
    "Reference Brand Name": "Cardura",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: doxazosin mesylate\nBrand Example: Cardura\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "doxepin hcl",
    "Reference Brand Name": "Sinequan",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: doxepin hcl\nBrand Example: Sinequan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "doxycycline",
    "Reference Brand Name": "Vibramycin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: doxycycline\nBrand Example: Vibramycin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Tetracyclines)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "droperidol",
    "Reference Brand Name": "Inapsine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: droperidol\nBrand Example: Inapsine\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "duloxetine hcl",
    "Reference Brand Name": "Cymbalta",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: duloxetine hcl\nBrand Example: Cymbalta\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "econazole nitrate",
    "Reference Brand Name": "Spectazole",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: econazole nitrate\nBrand Example: Spectazole\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "edoxaban tosylate",
    "Reference Brand Name": "Savaysa",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: edoxaban tosylate\nBrand Example: Savaysa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "eletriptan hydrobromide",
    "Reference Brand Name": "Relpax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: eletriptan hydrobromide\nBrand Example: Relpax\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "enoxaparin sodium",
    "Reference Brand Name": "Lovenox",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: enoxaparin sodium\nBrand Example: Lovenox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "epinastine hcl",
    "Reference Brand Name": "Elestat",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: epinastine hcl\nBrand Example: Elestat\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "erythromycin",
    "Reference Brand Name": "Ery-Tab",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: erythromycin\nBrand Example: Ery-Tab\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "erythromycin ophthalmic ointment",
    "Reference Brand Name": "Ilotycin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: erythromycin ophthalmic ointment\nBrand Example: Ilotycin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "escitalopram oxalate",
    "Reference Brand Name": "Lexapro",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: escitalopram oxalate\nBrand Example: Lexapro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "esketamine",
    "Reference Brand Name": "Spravato",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: esketamine\nBrand Example: Spravato\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "esomeprazole magnesium",
    "Reference Brand Name": "Nexium",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: esomeprazole magnesium \nBrand Example: Nexium\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "esomeprazole/naproxen",
    "Reference Brand Name": "Vimovo",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: esomeprazole/naproxen\nBrand Example: Vimovo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (Proton Pump Inhibitor /NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "estradiol",
    "Reference Brand Name": "Climara, Estraderm",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: estradiol\nBrand Example: Climara, Estraderm\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Estrogens\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "eszopiclone",
    "Reference Brand Name": "Lunesta",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: eszopiclone\nBrand Example: Lunesta\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "etanercept",
    "Reference Brand Name": "Enbrel",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: etanercept\nBrand Example: Enbrel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "etodolac",
    "Reference Brand Name": "Lodine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: etodolac\nBrand Example: Lodine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "famciclovir",
    "Reference Brand Name": "Famvir",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: famciclovir\nBrand Example: Famvir\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "famotidine",
    "Reference Brand Name": "Pepcid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: famotidine\nBrand Example: Pepcid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (H2 receptor blocker) \nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "famotidine/ibuprofen",
    "Reference Brand Name": "Duexis",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: famotidine/ibuprofen\nBrand Example: Duexis\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (H2 Receptor Blocker /NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fenoprofen calcium",
    "Reference Brand Name": "Nalfon",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fenoprofen calcium\nBrand Example: Nalfon\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fentanyl",
    "Reference Brand Name": "Duragesic",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fentanyl\nBrand Example: Duragesic\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fentanyl citrate oral transmucosal",
    "Reference Brand Name": "Actiq, Fentora",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fentanyl citrate oral transmucosal\nBrand Example: Actiq, Fentora\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluconazole",
    "Reference Brand Name": "Diflucan",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluconazole\nBrand Example: Diflucan\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluocinolone acetonide",
    "Reference Brand Name": "Synalar",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluocinolone acetonide\nBrand Example: Synalar\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluocinonide",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluocinonide\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nElbow Disorders: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluorometholone",
    "Reference Brand Name": "FML",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluorometholone\nBrand Example: FML\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluoxetine hcl",
    "Reference Brand Name": "Prozac",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluoxetine hcl\nBrand Example: Prozac\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "flurbiprofen",
    "Reference Brand Name": "Ansaid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: flurbiprofen\nBrand Example: Ansaid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "flurbiprofen sodium",
    "Reference Brand Name": "Ocufen",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: flurbiprofen sodium\nBrand Example: Ocufen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Inflammatory (NSAID) Ophthalmic Drops\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluticasone prop (topical)",
    "Reference Brand Name": "Cutivate",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluticasone prop (topical)\nBrand Example: Cutivate\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluticasone propionate",
    "Reference Brand Name": "Flovent",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluticasone propionate\nBrand Example: Flovent\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluticasone-salmeterol",
    "Reference Brand Name": "Advair",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluticasone-salmeterol\nBrand Example: Advair\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluvastatin sodium er",
    "Reference Brand Name": "Lescol XL",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluvastatin sodium er\nBrand Example: Lescol XL\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fluvoxamine maleate",
    "Reference Brand Name": "Luvox",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fluvoxamine maleate\nBrand Example: Luvox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "folic acid",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: folic acid\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hematopoietic Agents\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "fondaparinux sodium",
    "Reference Brand Name": "Arixtra",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: fondaparinux sodium\nBrand Example: Arixtra\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "formoterol fumarate",
    "Reference Brand Name": "Foradil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: formoterol fumarate\nBrand Example: Foradil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "formoterol/mometasone",
    "Reference Brand Name": "Dulera",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: formoterol/mometasone\nBrand Example: Dulera\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "frovatriptan succinate",
    "Reference Brand Name": "Frova",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: frovatriptan succinate\nBrand Example: Frova\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "gabapentin",
    "Reference Brand Name": "Neurontin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: gabapentin\nBrand Example: Neurontin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: 4 Days\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended, No Recommendation\nChronic Pain: Recommended\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "gabapentin (once-daily)",
    "Reference Brand Name": "Gralise",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: gabapentin (once-daily)\nBrand Example: Gralise\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nAnxiety Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "gabapentin enacarbil",
    "Reference Brand Name": "Horizant",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: gabapentin enacarbil\nBrand Example: Horizant\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nAnxiety Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "gatifloxacin",
    "Reference Brand Name": "Zymaxid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: gatifloxacin\nBrand Example: Zymaxid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "gentamicin (topical)",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: gentamicin (topical)\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "gentamicin sulfate ophthalmic",
    "Reference Brand Name": "Gentak",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: gentamicin sulfate ophthalmic\nBrand Example: Gentak\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "glucosamine sulfate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: glucosamine sulfate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines (OTC nutraceutical)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "golimumab",
    "Reference Brand Name": "Simponi",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: golimumab\nBrand Example: Simponi\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "granisetron hcl",
    "Reference Brand Name": "Kytril",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: granisetron hcl\nBrand Example: Kytril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "guanfacine er",
    "Reference Brand Name": "Intuniv",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: guanfacine er\nBrand Example: Intuniv\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: ADHD/Anti-Narcolepsy/Anti-Obesity/Anorexiants\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "guanfacine hcl",
    "Reference Brand Name": "Tenex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: guanfacine hcl\nBrand Example: Tenex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "heparin sodium",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: heparin sodium\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "homatropine hbr ophthalmic",
    "Reference Brand Name": "Isopto Homatropine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: homatropine hbr ophthalmic\nBrand Example: Isopto Homatropine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines:\nEye: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydrochlorothiazide",
    "Reference Brand Name": "Microzide",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydrochlorothiazide\nBrand Example: Microzide\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Diuretics\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydrocodone bitartrate",
    "Reference Brand Name": "Hysingla ER",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydrocodone bitartrate\nBrand Example: Hysingla ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydrocodone/acetaminophen",
    "Reference Brand Name": "Norco, Vicodin, Xodol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydrocodone/acetaminophen\nBrand Example: Norco, Vicodin, Xodol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydrocodone/ibuprofen",
    "Reference Brand Name": "Vicoprofen",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydrocodone/ibuprofen\nBrand Example: Vicoprofen\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydrocortisone",
    "Reference Brand Name": "Cortef",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydrocortisone\nBrand Example: Cortef\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nCOVID-19 Coronavirus: Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nKnee Disorders: No Recommendation\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydrocortisone (topical)",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydrocortisone (topical)\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydrocortisone valerate",
    "Reference Brand Name": "Westcort",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydrocortisone valerate\nBrand Example: Westcort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydromorphone hcl",
    "Reference Brand Name": "Dilaudid, Exalgo",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydromorphone hcl\nBrand Example: Dilaudid, Exalgo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydroxychloroquine sulfate",
    "Reference Brand Name": "Plaquenil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydroxychloroquine sulfate\nBrand Example: Plaquenil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antimalarials\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydroxyzine hcl",
    "Reference Brand Name": "Atarax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydroxyzine hcl\nBrand Example: Atarax\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hydroxyzine pamoate",
    "Reference Brand Name": "Vistaril",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hydroxyzine pamoate\nBrand Example: Vistaril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "hypromellose ophthalmic gel",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: hypromellose ophthalmic gel\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ibandronate sodium",
    "Reference Brand Name": "Boniva",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ibandronate sodium\nBrand Example: Boniva\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ibuprofen",
    "Reference Brand Name": "Motrin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ibuprofen\nBrand Example: Motrin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "imipramine hcl",
    "Reference Brand Name": "Tofranil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: imipramine hcl\nBrand Example: Tofranil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "imipramine pamoate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: imipramine pamoate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "indomethacin",
    "Reference Brand Name": "Indocin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: indomethacin\nBrand Example: Indocin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "inositol",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: inositol\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Nutrients\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "irrigating eyewash",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: irrigating eyewash\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "isocarboxazid",
    "Reference Brand Name": "Marplan",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: isocarboxazid\nBrand Example: Marplan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "itraconazole",
    "Reference Brand Name": "Sporanox",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: itraconazole\nBrand Example: Sporanox\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ivermectin",
    "Reference Brand Name": "Stomectol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ivermectin\nBrand Example: Stomectol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihelmintics\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ketoconazole",
    "Reference Brand Name": "Nizoral",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ketoconazole\nBrand Example: Nizoral\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ketoprofen",
    "Reference Brand Name": "Oruvail",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ketoprofen\nBrand Example: Oruvail\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ketorolac tromethamine",
    "Reference Brand Name": "Toradol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ketorolac tromethamine\nBrand Example: Toradol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ketorolac tromethamine ophthalmic",
    "Reference Brand Name": "Acular",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ketorolac tromethamine ophthalmic\nBrand Example: Acular\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ketotifen fumarate",
    "Reference Brand Name": "Zaditor",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ketotifen fumarate\nBrand Example: Zaditor\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lamotrigine",
    "Reference Brand Name": "Lamictal",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lamotrigine\nBrand Example: Lamictal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lansoprazole",
    "Reference Brand Name": "Prevacid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lansoprazole\nBrand Example: Prevacid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lenalidomide",
    "Reference Brand Name": "Revlimid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lenalidomide\nBrand Example: Revlimid\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Miscellaneous Therapeutic Classes\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "levalbuterol",
    "Reference Brand Name": "Xopenex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: levalbuterol\nBrand Example: Xopenex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "levetiracetam",
    "Reference Brand Name": "Keppra",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: levetiracetam\nBrand Example: Keppra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "levofloxacin",
    "Reference Brand Name": "Levaquin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: levofloxacin\nBrand Example: Levaquin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "levofloxacin ophthalmic solution",
    "Reference Brand Name": "Quixin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: levofloxacin ophthalmic solution\nBrand Example: Quixin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "levomilnacipran",
    "Reference Brand Name": "Fetzima",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: levomilnacipran\nBrand Example: Fetzima\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "levorphanol tartrate",
    "Reference Brand Name": "Levo-Dromoran",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: levorphanol tartrate\nBrand Example: Levo-Dromoran\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lidocaine",
    "Reference Brand Name": "Lidoderm",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lidocaine\nBrand Example: Lidoderm\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals \nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lidocaine hcl",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lidocaine hcl\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lidocaine hcl ophth",
    "Reference Brand Name": "Akten",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lidocaine hcl ophth\nBrand Example: Akten\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Opthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lidocaine/prilocaine",
    "Reference Brand Name": "Emla",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lidocaine/prilocaine\nBrand Example: Emla\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lithium carbonate",
    "Reference Brand Name": "Lithobid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lithium carbonate\nBrand Example: Lithobid\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lofexidine",
    "Reference Brand Name": "Lucemyra",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lofexidine\nBrand Example: Lucemyra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nOpioids: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lopinavir/ritonavir",
    "Reference Brand Name": "Kaletra",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lopinavir/ritonavir\nBrand Example: Kaletra\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "loratadine",
    "Reference Brand Name": "Claritin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: loratadine\nBrand Example: Claritin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lorazepam",
    "Reference Brand Name": "Ativan",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lorazepam\nBrand Example: Ativan\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days \nPeri-Op: Not Applicable \nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "loteprednol etabonate ophthalmic",
    "Reference Brand Name": "Alrex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: loteprednol etabonate ophthalmic\nBrand Example: Alrex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lovastatin",
    "Reference Brand Name": "Mevacor",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lovastatin\nBrand Example: Mevacor \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "lurasidone",
    "Reference Brand Name": "Latuda",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: lurasidone\nBrand Example: Latuda\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "magnesium",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: magnesium\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Minerals & Electrolytes\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "meclizine hcl",
    "Reference Brand Name": "Antivert",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: meclizine hcl\nBrand Example: Antivert\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "meclofenamate sodium",
    "Reference Brand Name": "Meclomen",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: meclofenamate sodium\nBrand Example: Meclomen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "medroxyprogesterone",
    "Reference Brand Name": "Provera",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: medroxyprogesterone\nBrand Example: Provera\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Progestins\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "mefenamic acid",
    "Reference Brand Name": "Ponstel",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: mefenamic acid\nBrand Example: Ponstel\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "melatonin",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: melatonin\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "meloxicam",
    "Reference Brand Name": "Mobic",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: meloxicam\nBrand Example: Mobic\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "memantine hcl",
    "Reference Brand Name": "Namenda",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: memantine hcl\nBrand Example: Namenda\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\n(NDMA Receptor Antagonist)\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "menthol",
    "Reference Brand Name": "Bengay Ultra, Biofreeze",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: menthol\nBrand Example: Bengay Ultra, Biofreeze\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "meperidine hcl",
    "Reference Brand Name": "Demerol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: meperidine hcl\nBrand Example: Demerol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "metaxalone",
    "Reference Brand Name": "Skelaxin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: metaxalone\nBrand Example: Skelaxin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "methadone hcl",
    "Reference Brand Name": "Dolophine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: methadone hcl\nBrand Example: Dolophine\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "methocarbamol",
    "Reference Brand Name": "Robaxin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: methocarbamol\nBrand Example: Robaxin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "methyl salicylate",
    "Reference Brand Name": "Bengay Ultra",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: methyl salicylate\nBrand Example: Bengay Ultra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "methylphenidate hydrochloride",
    "Reference Brand Name": "Ritalin, Concerta",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: methylphenidate hydrochloride\nBrand Example: Ritalin, Concerta\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: ADHD / Anti-narcolepsy / Anti-Obesity / Anorexiants\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "methylprednisolone",
    "Reference Brand Name": "Medrol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: methylprednisolone\nBrand Example: Medrol\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nCOVID-19 Coronavirus: Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "methylsulfonylmethane",
    "Reference Brand Name": "MSM",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: methylsulfonylmethane\nBrand Example: MSM\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals (OTC nutraceuticals)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "metoclopramide hcl",
    "Reference Brand Name": "Reglan",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: metoclopramide hcl\nBrand Example: Reglan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "metronidazole",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: metronidazole \nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "metronidazole oral",
    "Reference Brand Name": "Flagyl",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: metronidazole oral\nBrand Example: Flagyl\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "miconazole nitrate",
    "Reference Brand Name": "Micatin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: miconazole nitrate\nBrand Example: Micatin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "midazolam hcl",
    "Reference Brand Name": "Versed",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: midazolam hcl\nBrand Example: Versed\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "mifepristone",
    "Reference Brand Name": "Mifeprex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: mifepristone\nBrand Example: Mifeprex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents - (misc)\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "milnacipran",
    "Reference Brand Name": "Savella",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: milnacipran\nBrand Example: Savella\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc. (Anti-depressant)\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "minocycline hcl",
    "Reference Brand Name": "Minocin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: minocycline hcl\nBrand Example: Minocin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Tetracyclines) \nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "mirtazapine",
    "Reference Brand Name": "Remeron",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: mirtazapine\nBrand Example: Remeron\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "misoprostol",
    "Reference Brand Name": "Cytotec",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: misoprostol\nBrand Example: Cytotec\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "modafinil",
    "Reference Brand Name": "Provigil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: modafinil\nBrand Example: Provigil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: ADHD / Anti-narcolepsy / Anti-Obesity / Anorexiants\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "mometasone furoate",
    "Reference Brand Name": "Asmanex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: mometasone furoate\nBrand Example: Asmanex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "mometasone furoate (topical)",
    "Reference Brand Name": "Elocon",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: mometasone furoate (topical)\nBrand Example: Elocon\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "montelukast sodium",
    "Reference Brand Name": "Singluair",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: montelukast sodium\nBrand Example: Singluair\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "morphine sulfate",
    "Reference Brand Name": "MSIR",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: morphine sulfate\nBrand Example: MSIR\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "morphine sulfate extended release",
    "Reference Brand Name": "MS Contin, Kadian, Avinza",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: morphine sulfate extended release\nBrand Example: MS Contin, Kadian, Avinza\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "moxifloxacin hcl",
    "Reference Brand Name": "Avelox",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: moxifloxacin hcl\nBrand Example: Avelox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "moxifloxacin hcl ophthalmic",
    "Reference Brand Name": "Vigamox",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: moxifloxacin hcl ophthalmic\nBrand Example: Vigamox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "mupirocin",
    "Reference Brand Name": "Bactroban",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: mupirocin\nBrand Example: Bactroban\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "mycophenolate mofetil",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: mycophenolate mofetil\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Not Applicable\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nabilone",
    "Reference Brand Name": "Cesamet",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nabilone\nBrand Example: Cesamet\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nabumetone",
    "Reference Brand Name": "Relafen",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nabumetone\nBrand Example: Relafen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "n-acetyl-l-cysteine",
    "Reference Brand Name": "NAC",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: n-acetyl-l-cysteine\nBrand Example: NAC\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Nutrients\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "naloxone hcl",
    "Reference Brand Name": "Narcan, Zimhi, Kloxxado",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: naloxone hcl\nBrand Example: Narcan, Zimhi, Kloxxado\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidotes and Specific Antagonists\nReference in ACOEM Guidelines:\nOpioid: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "naltrexone hydrochloride",
    "Reference Brand Name": "Revia",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: naltrexone hydrochloride\nBrand Example: Revia\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidotes and Specific Antagonists\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nOpioids: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "naproxen",
    "Reference Brand Name": "Aleve, Naprosyn",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: naproxen\nBrand Example: Aleve, Naprosyn\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "naratriptan hcl",
    "Reference Brand Name": "Amerge",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: naratriptan hcl\nBrand Example: Amerge\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "natamycin ophth",
    "Reference Brand Name": "Natacyn",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: natamycin ophth\nBrand Example: Natacyn\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nedocromil",
    "Reference Brand Name": "Alocril",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nedocromil\nBrand Example: Alocril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophtalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nefazodone hcl",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nefazodone hcl\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "neomycin sulfate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: neomycin sulfate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "neomycin/polymyxin b/bacitracin",
    "Reference Brand Name": "Neosporin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: neomycin/polymyxin b/bacitracin\nBrand Example: Neosporin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nifedipine",
    "Reference Brand Name": "Procardia",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nifedipine\nBrand Example: Procardia\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Calcium Channel Blockers\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nitroglycerin transdermal",
    "Reference Brand Name": "Nitro-Dur",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nitroglycerin transdermal\nBrand Example: Nitro-Dur\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antianginal Agents (Glyceril trinitrate patches)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nizatidine",
    "Reference Brand Name": "Axid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nizatidine\nBrand Example: Axid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (H2 receptor blocker) \nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nortriptyline hcl",
    "Reference Brand Name": "Pamelor",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nortriptyline hcl\nBrand Example: Pamelor\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "nystatin/triamcinolone",
    "Reference Brand Name": "Mycolog II",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: nystatin/triamcinolone\nBrand Example: Mycolog II\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ofloxacin",
    "Reference Brand Name": "Floxin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ofloxacin\nBrand Example: Floxin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Fluoroquinolones\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ofloxacin ophthalmic solution",
    "Reference Brand Name": "Ocuflox",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ofloxacin ophthalmic solution\nBrand Example: Ocuflox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "olanzapine",
    "Reference Brand Name": "Zyprexa",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: olanzapine\nBrand Example: Zyprexa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDepressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "olanzapine/fluoxetine",
    "Reference Brand Name": "Symbyax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: olanzapine/fluoxetine\nBrand Example: Symbyax\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurologic Agents - Misc.\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "olopatadine hcl",
    "Reference Brand Name": "Pataday, Patanol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: olopatadine hcl\nBrand Example: Pataday, Patanol\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "omega-3",
    "Reference Brand Name": "Omega-3 Fatty Acids",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: omega-3\nBrand Example: Omega-3 Fatty Acids\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Nutrients\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "omeprazole",
    "Reference Brand Name": "Prilosec",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: omeprazole\nBrand Example: Prilosec\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ondansetron",
    "Reference Brand Name": "Zofran ODT",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ondansetron\nBrand Example: Zofran ODT\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ondansetron hcl",
    "Reference Brand Name": "Zofran",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ondansetron hcl\nBrand Example: Zofran\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "orphenadrine citrate",
    "Reference Brand Name": "Norflex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: orphenadrine citrate\nBrand Example: Norflex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxaprozin",
    "Reference Brand Name": "Daypro",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxaprozin\nBrand Example: Daypro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxazepam",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxazepam\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxcarbazepine",
    "Reference Brand Name": "Trileptal",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxcarbazepine\nBrand Example: Trileptal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxycodone er",
    "Reference Brand Name": "OxyContin, Xtampza ER",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxycodone er\nBrand Example: OxyContin, Xtampza ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Not Applicable\nReference in ACOEM Guidelines:\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxycodone hcl",
    "Reference Brand Name": "Roxicodone",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxycodone hcl\nBrand Example: Roxicodone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxycodone/acetaminophen",
    "Reference Brand Name": "Percocet",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxycodone/acetaminophen\nBrand Example: Percocet\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: 4 days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxymorphone hydrochloride",
    "Reference Brand Name": "Opana, Opana ER",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxymorphone hydrochloride\nBrand Example: Opana, Opana ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "oxytocin",
    "Reference Brand Name": "Pitocin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: oxytocin\nBrand Example: Pitocin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Oxytocics\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pantoprazole sodium",
    "Reference Brand Name": "Protonix",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pantoprazole sodium\nBrand Example: Protonix\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "paroxetine hcl",
    "Reference Brand Name": "Paxil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: paroxetine hcl\nBrand Example: Paxil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "penicillin v potassium",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: penicillin v potassium\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pentazocine/naloxone hcl",
    "Reference Brand Name": "Talwin NX",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pentazocine/naloxone hcl\nBrand Example: Talwin NX\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pentoxifylline",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pentoxifylline\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hematological Agents - Misc.\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "perphenazine",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: perphenazine\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "phenelzine sulfate",
    "Reference Brand Name": "Nardil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: phenelzine sulfate\nBrand Example: Nardil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "phenobarbital",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: phenobarbital\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "phenytoin",
    "Reference Brand Name": "Dilantin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: phenytoin\nBrand Example: Dilantin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pioglitazone hcl",
    "Reference Brand Name": "Actos",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pioglitazone hcl\nBrand Example: Actos\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidiabetics\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "piroxicam",
    "Reference Brand Name": "Feldene",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: piroxicam\nBrand Example: Feldene\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pitavastatin calcium",
    "Reference Brand Name": "Livalo",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pitavastatin calcium\nBrand Example: Livalo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pitavastatin magnesium",
    "Reference Brand Name": "Zypitamag",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pitavastatin magnesium\nBrand Example: Zypitamag\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "polyvinyl alcohol 1.4% lu",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: polyvinyl alcohol 1.4% lu\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "polyvinyl alcohol-povidine (ophth)",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: polyvinyl alcohol-povidine (ophth)\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pramipexole dihydrochloride",
    "Reference Brand Name": "Mirapex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pramipexole dihydrochloride\nBrand Example: Mirapex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiparkinson and Related Therapy Agents\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pravastatin sodium",
    "Reference Brand Name": "Pravachol",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pravastatin sodium\nBrand Example: Pravachol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Non-Exempt\nPeri-Op: Not Applicable \nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "prazosin hcl",
    "Reference Brand Name": "Minpress",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: prazosin hcl\nBrand Example: Minpress\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "prednisolone",
    "Reference Brand Name": "Orapred",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: prednisolone\nBrand Example: Orapred\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "prednisolone acetate",
    "Reference Brand Name": "Pred Forte, Pred Mild",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: prednisolone acetate\nBrand Example: Pred Forte, Pred Mild\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "prednisolone sodium ophth",
    "Reference Brand Name": "Omnipred",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: prednisolone sodium ophth\nBrand Example: Omnipred\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "prednisone",
    "Reference Brand Name": "Sterapred",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: prednisone\nBrand Example: Sterapred\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pregabalin",
    "Reference Brand Name": "Lyrica",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pregabalin\nBrand Example: Lyrica\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pregabalin (once-daily)",
    "Reference Brand Name": "Lyrica CR",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pregabalin (once-daily)\nBrand Example: Lyrica CR\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nAnxiety Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "probenecid",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: probenecid\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Gout Agents\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "prochlorperazine maleate",
    "Reference Brand Name": "Compazine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: prochlorperazine maleate\nBrand Example: Compazine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "progesterone",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: progesterone\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Progestins\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "promethazine hcl",
    "Reference Brand Name": "Phenergan",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: promethazine hcl\nBrand Example: Phenergan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "proparacaine hcl",
    "Reference Brand Name": "Alcaine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: proparacaine hcl\nBrand Example: Alcaine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anesthetic)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "propranolol hcl",
    "Reference Brand Name": "Inderal",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: propranolol hcl\nBrand Example: Inderal\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Beta Blockers\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "protriptyline hcl",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: protriptyline hcl\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "pyridostigmine bromide",
    "Reference Brand Name": "Mestinon",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: pyridostigmine bromide\nBrand Example: Mestinon\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antimyasthenic / Cholinergic Agents\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "quetiapine fumarate",
    "Reference Brand Name": "Seroquel",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: quetiapine fumarate\nBrand Example: Seroquel\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nChronic Pain: No Recommendation\nDepressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "rabeprazole sodium",
    "Reference Brand Name": "Aciphex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: rabeprazole sodium\nBrand Example: Aciphex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "raloxifene hydrochloride",
    "Reference Brand Name": "Evista",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: raloxifene hydrochloride\nBrand Example: Evista\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. \nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "regular insulin",
    "Reference Brand Name": "Humulin R",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: regular insulin\nBrand Example: Humulin R\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidiabetics\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ribavirin",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ribavirin\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "riboflavin",
    "Reference Brand Name": "Vitamin B-2",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: riboflavin\nBrand Example: Vitamin B-2\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "risedronate sodium",
    "Reference Brand Name": "Actonel",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: risedronate sodium\nBrand Example: Actonel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "risperidone",
    "Reference Brand Name": "Risperdal",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: risperidone\nBrand Example: Risperdal\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "rivaroxaban",
    "Reference Brand Name": "Xarelto",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: rivaroxaban\nBrand Example: Xarelto\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "rivastigmine tartrate",
    "Reference Brand Name": "Exelon",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: rivastigmine tartrate\nBrand Example: Exelon\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "rizatriptan benzoate",
    "Reference Brand Name": "Maxalt",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: rizatriptan benzoate\nBrand Example: Maxalt\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "rolapitant",
    "Reference Brand Name": "Varubi",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: rolapitant\nBrand Example: Varubi\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "rosuvastatin calcium",
    "Reference Brand Name": "Crestor",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: rosuvastatin calcium\nBrand Example: Crestor\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "s-adenosylmethionine",
    "Reference Brand Name": "SAM E",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: s-adenosylmethionine\nBrand Example: SAM E\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "salmeterol",
    "Reference Brand Name": "Serevent",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: salmeterol\nBrand Example: Serevent\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "salsalate",
    "Reference Brand Name": "Disalcid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: salsalate\nBrand Example: Disalcid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "scopolamine",
    "Reference Brand Name": "Transderm Scop",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: scopolamine\nBrand Example: Transderm Scop\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "selegiline",
    "Reference Brand Name": "Emsam",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: selegiline\nBrand Example: Emsam\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "sertraline hcl",
    "Reference Brand Name": "Zoloft",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: sertraline hcl\nBrand Example: Zoloft\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines:\nAnxiety Disorder: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "silver sulfadiazine",
    "Reference Brand Name": "Silvadene",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: silver sulfadiazine\nBrand Example: Silvadene\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "simvastatin",
    "Reference Brand Name": "Zocor",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: simvastatin\nBrand Example: Zocor\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "sodium chloride ophthalmic",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: sodium chloride ophthalmic\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "sodium oxybate",
    "Reference Brand Name": "Xyrem",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: sodium oxybate\nBrand Example: Xyrem\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "sucralfate",
    "Reference Brand Name": "Carafate",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: sucralfate\nBrand Example: Carafate\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "sulfamethoxazole/trimethoprim",
    "Reference Brand Name": "Bactrim",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: sulfamethoxazole/trimethoprim\nBrand Example: Bactrim\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\n: \nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "sulindac",
    "Reference Brand Name": "Clinoril",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: sulindac\nBrand Example: Clinoril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "sumatriptan succinate",
    "Reference Brand Name": "Imitrex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: sumatriptan succinate\nBrand Example: Imitrex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tacrolimus",
    "Reference Brand Name": "Protopic",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tacrolimus \nBrand Example: Protopic\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tapentadol",
    "Reference Brand Name": "Nucynta, Nucynta ER",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tapentadol\nBrand Example: Nucynta, Nucynta ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "temazepam",
    "Reference Brand Name": "Restoril",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: temazepam\nBrand Example: Restoril\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "terbinafine hcl",
    "Reference Brand Name": "Lamisil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: terbinafine hcl\nBrand Example: Lamisil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "terbinafine hcl (topical)",
    "Reference Brand Name": "Lamisil",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: terbinafine hcl (topical)\nBrand Example: Lamisil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tetracaine hcl",
    "Reference Brand Name": "Tetcaine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tetracaine hcl\nBrand Example: Tetcaine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anesthetic)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tetracycline hcl",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tetracycline hcl\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Tetracyclines \nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "thalidomide",
    "Reference Brand Name": "Thalomid",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: thalidomide\nBrand Example: Thalomid\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Assorted Classes\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "theophylline",
    "Reference Brand Name": "Theo-24, Theo-Dur",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: theophylline\nBrand Example: Theo-24, Theo-Dur\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tiagabine hcl",
    "Reference Brand Name": "Gabitril",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tiagabine hcl\nBrand Example: Gabitril\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tizanidine hcl",
    "Reference Brand Name": "Zanaflex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tizanidine hcl\nBrand Example: Zanaflex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tobramycin ophthalmic",
    "Reference Brand Name": "Tobrex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tobramycin ophthalmic\nBrand Example: Tobrex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tolmetin sodium",
    "Reference Brand Name": "Tolectin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tolmetin sodium\nBrand Example: Tolectin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tolnaftate",
    "Reference Brand Name": "Tinactin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tolnaftate\nBrand Example: Tinactin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "topiramate",
    "Reference Brand Name": "Topamax",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: topiramate\nBrand Example: Topamax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tramadol hcl",
    "Reference Brand Name": "Ultram",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tramadol hcl\nBrand Example: Ultram\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tramadol hcl/acetaminophen",
    "Reference Brand Name": "Ultracet",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tramadol hcl/acetaminophen\nBrand Example: Ultracet\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tranexamic acid",
    "Reference Brand Name": "Lysteda",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tranexamic acid\nBrand Example: Lysteda\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hemostatics\nReference in ACOEM Guidelines:\nEye: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tranylcypromine",
    "Reference Brand Name": "Parnate",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tranylcypromine\nBrand Example: Parnate\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "trazodone hcl",
    "Reference Brand Name": "Desyrel, Oleptro",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: trazodone hcl\nBrand Example: Desyrel, Oleptro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, No Recommendation\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "triamcinolone acetonide i",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: triamcinolone acetonide i\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "trimipramine maleate",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: trimipramine maleate\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "trolamine salicylate",
    "Reference Brand Name": "Arthricream",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: trolamine salicylate\nBrand Example: Arthricream\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "tropicamide ophthalmic",
    "Reference Brand Name": "Mydriacyl",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: tropicamide ophthalmic\nBrand Example: Mydriacyl\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines:\nEye: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "trypsin",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: trypsin\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals (Proteolytic enzyme)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "valacyclovir hcl",
    "Reference Brand Name": "Valtrex",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: valacyclovir hcl\nBrand Example: Valtrex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "valproic acid",
    "Reference Brand Name": "Depakene",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: valproic acid\nBrand Example: Depakene\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: No Recommendation\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "venlafaxine hcl",
    "Reference Brand Name": "Effexor",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: venlafaxine hcl\nBrand Example: Effexor\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vilazodone",
    "Reference Brand Name": "Viibryd",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vilazodone\nBrand Example: Viibryd\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin a",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin a\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin b-1",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin b-1\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin b-12",
    "Reference Brand Name": "Cyanocobalamin, Methylcobalamin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin b-12\nBrand Example: Cyanocobalamin, Methylcobalamin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hematopoietic Agents (Vitamins)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Not Recommended\nElbow Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin b-6",
    "Reference Brand Name": "Pyridoxine",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin b-6\nBrand Example: Pyridoxine\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin d",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin d\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin d3",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin d3\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended\nChronic Pain: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vitamin e",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vitamin e\nBrand Example: Not Applicable \nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "vortioxetine",
    "Reference Brand Name": "Trintellix",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: vortioxetine\nBrand Example: Trintellix\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "warfarin sodium",
    "Reference Brand Name": "Coumadin",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: warfarin sodium\nBrand Example: Coumadin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "zafirlukast",
    "Reference Brand Name": "Accolate",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: zafirlukast\nBrand Example: Accolate\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "zileuton",
    "Reference Brand Name": "Zyflo",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: zileuton\nBrand Example: Zyflo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "zinc",
    "Reference Brand Name": "Not Applicable",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: zinc\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Minerals & Electrolytes\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "ziprasidone hcl",
    "Reference Brand Name": "Geodon",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: ziprasidone hcl\nBrand Example: Geodon\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "zolmitriptan",
    "Reference Brand Name": "Zomig",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: zolmitriptan\nBrand Example: Zomig\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "zolpidem tartrate",
    "Reference Brand Name": "Ambien",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: zolpidem tartrate\nBrand Example: Ambien\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "Drug Ingredient": "zonisamide",
    "Reference Brand Name": "Zonegran",
    "General citation (All body parts)": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.13 (Effective August 6, 2025)\nDrug Formulary\nDrug Ingredient: zonisamide\nBrand Example: Zonegran\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier(s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd.",
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  }
]
